Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
3.500
+0.060 (1.74%)
Nov 21, 2024, 11:34 AM EST - Market open
Arbutus Biopharma Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$5.50
Upside
+57.14%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Chardan Capital | Chardan Capital | Strong Buy Maintains $4.5 → $5 | Strong Buy | Maintains | $4.5 → $5 | +42.86% | Nov 20, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +42.86% | Nov 18, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +42.86% | Nov 7, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $4 → $4.5 | Strong Buy | Maintains | $4 → $4.5 | +28.57% | Nov 6, 2024 |
Jefferies | Jefferies | Strong Buy Maintains $5 → $7 | Strong Buy | Maintains | $5 → $7 | +100.00% | Sep 5, 2024 |
JMP Securities | JMP Securities | Buy Maintains $4 → $5 | Buy | Maintains | $4 → $5 | +42.86% | Aug 2, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +42.86% | Jun 7, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +42.86% | Jun 6, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +14.29% | Jun 5, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +14.29% | May 3, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $4 | Buy | Reiterates | $4 | +14.29% | Apr 4, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +14.29% | Mar 1, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +42.86% | Mar 1, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +71.43% | Sep 12, 2023 |
Chardan Capital | Chardan Capital | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +71.43% | Aug 4, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +71.43% | Aug 4, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.